Reporting of MABp1 for the Treatment of Psoriasis
- PMID: 26465764
- DOI: 10.1001/jamadermatol.2015.1684
Reporting of MABp1 for the Treatment of Psoriasis
Comment in
-
In Reply.JAMA Dermatol. 2015 Oct;151(10):1144. doi: 10.1001/jamadermatol.2015.1683. JAMA Dermatol. 2015. PMID: 26465767 No abstract available.
Comment on
-
Open-Label Trial of MABp1, a True Human Monoclonal Antibody Targeting Interleukin 1α, for the Treatment of Psoriasis.JAMA Dermatol. 2015 May;151(5):555-6. doi: 10.1001/jamadermatol.2014.5391. JAMA Dermatol. 2015. PMID: 25715176 Clinical Trial. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical